9975 Summers Ridge Road
San Diego, CA 92121
United States
858-552-1100
https://www.quidelortho.com
Secteur(s): Healthcare
Secteur d’activité: Medical Instruments & Supplies
Employés à temps plein: 1 600
Nom | Titre | Payer | Exercé | Année de naissance |
---|---|---|---|---|
Mr. Douglas C. Bryant | Chairman & CEO | 1,41M | S.O. | 1958 |
Mr. Robert J. Bujarski J.D. | Pres & COO | 770,62k | S.O. | 1969 |
Ms. Michelle A. Hodges | Gen. Counsel | 620,61k | S.O. | 1960 |
Dr. Werner Kroll Ph.D. | Sr. VP of R&D | 758,22k | 2,1M | 1957 |
Mr. Joseph M. Busky CPA | Chief Financial Officer | S.O. | S.O. | 1968 |
Ruben Argueta | Director of Investor Relations | S.O. | S.O. | S.O. |
Mr. Michael S. Iskra | Chief Commercial Officer | S.O. | S.O. | 1970 |
Phillip S. Askim | VP, Associate Gen. Counsel & Sec. | S.O. | S.O. | S.O. |
Dr. Johannes Kehle | Pres of AnDiaTec Division | S.O. | S.O. | S.O. |
Mr. Rhys de Callier | VP of Strategy & Portfolio Management | S.O. | S.O. | S.O. |
QuidelOrtho Corporation provides various in vitro diagnostics products worldwide. The company's product portfolio covers a range of point-of-care tests for infectious diseases, critical cardiac health and autoimmune biomarkers, and clinical and at-home products to detect COVID-19. It provides visually-read lateral flow products in infectious disease and reproductive health; direct fluorescent antibodies in infectious disease and virology; micro-titer production with a focus on bone and complement pathway markets; fluorescent immunoassay products; molecular diagnostic products comprising Savanna, an integrated molecular diagnostic system; immunodiagnostics, clinical chemistry, and integrated testing systems to serve diagnostic labs of all sizes; immunodiagnostic donor screening systems and services that drive blood safety; pre-transfusion testing that automates blood bank workload with software to standardize operations, simplify tasks, and improve productivity; and Ortho Care services and informatics products. The company was founded in 1979 and is headquartered in San Diego, California.
L’ISS Governance QualityScore de QuidelOrtho Corporation en date du 1 juillet 2022 est 4. Les scores principaux sont Audit : 8; Société : 3; Droits des actionnaires : 3; Compensation : 4.